Ophthalmology · New Haven, CT
NPI
1003253733
Since 2013
Specialty
Ophthalmology
Code 390200000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
20 York St # T-209, Yale-New Haven Hospital
New Haven, CT, 06510
Phone (203) 789-3989
Groups this clinician bills Medicare through
Medicare paid, 2024
$5,608
37 services
Medicare patients, 2024
20
Average age 70
Drug cost, 2024
$518K
4,494 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Chengjie Zheng prescribed most often to Medicare patients was Latanoprost, with 828 prescriptions and refills. In total Chengjie Zheng wrote 4,494 Medicare prescriptions that cost $518K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-11-03.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Latanoprost Generic | 828 | 1,890 | 281 | $9,997 |
| Brimonidine Tartrate Generic | 559 | 1,580 | 207 | $13K |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 542 | 1,582 | 180 | $14K |
| Prednisolone Acetate Generic | 433 | 698 | 258 | $22K |
| Ketorolac Tromethamine Generic | 234 | 239 | 169 | $3,848 |
| Rhopressa Netarsudil Mesylate | 196 | 452 | 62 | $136K |
| Timolol Maleate Generic | 185 | 531 | 68 | $3,358 |
| Vyzulta Latanoprostene Bunod | 179 | 384 | 55 | $100K |
| Ofloxacin Generic | 175 | 175 | 139 | $2,633 |
| Bimatoprost Generic | 137 | 356 | 44 | $13K |
| Dorzolamide Hcl Generic | 133 | 379 | 48 | $3,185 |
| Dorzolamide-Timolol Dorzolamide/Timolol/Pf | 106 | 146 | 22 | $14K |
| Acetazolamide Er Acetazolamide | 86 | 139 | 22 | $3,922 |
| Travoprost Generic | 72 | 187 | 29 | $4,876 |
| Timolol Maleate Timolol Maleate/Pf | 67 | 103 | 13 | $18K |
Brand drugs: 1,169 claims; generic drugs: 3,325 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Chengjie Zheng were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.